SOX9 and neoplasm: In recent years, nanotechnology has made remarkable progress in medicine, particularly in tumor drug delivery and immunotherapy.[38, 39] Here, we designed PLGA NPs encapsulating si‐SOX9 and Ce6, further modified with iRGD peptides to enhance tumor targeting.